Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, USA.
Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Nat Commun. 2023 Dec 9;14(1):8159. doi: 10.1038/s41467-023-43795-x.
Autosomal Recessive Renal Tubular Dysgenesis (AR-RTD) is a fatal genetic disorder characterized by complete absence or severe depletion of proximal tubules (PT) in patients harboring pathogenic variants in genes involved in the Renin-Angiotensin-Aldosterone System. To uncover the pathomechanism of AR-RTD, differentiation of ACE-/- and AGTR1-/- induced pluripotent stem cells (iPSCs) and AR-RTD patient-derived iPSCs into kidney organoids is leveraged. Comprehensive marker analyses show that both mutant and control organoids generate indistinguishable PT in vitro under normoxic (21% O2) or hypoxic (2% O2) conditions. Fully differentiated (d24) AGTR1-/- and control organoids transplanted under the kidney capsule of immunodeficient mice engraft and mature well, as do renal vesicle stage (d14) control organoids. By contrast, d14 AGTR1-/- organoids fail to engraft due to insufficient pro-angiogenic VEGF-A expression. Notably, growth under hypoxic conditions induces VEGF-A expression and rescues engraftment of AGTR1-/- organoids at d14, as does ectopic expression of VEGF-A. We propose that PT dysgenesis in AR-RTD is primarily a non-autonomous consequence of delayed angiogenesis, starving PT at a critical time in their development.
常染色体隐性肾单位发育不良(AR-RTD)是一种致命的遗传疾病,其特征是携带肾素-血管紧张素-醛固酮系统相关基因致病性变异的患者近端小管(PT)完全缺失或严重耗竭。为了揭示 AR-RTD 的发病机制,利用 ACE-/-和 AGTR1-/-诱导多能干细胞(iPSCs)和 AR-RTD 患者来源的 iPSCs 分化为肾类器官。全面的标志物分析表明,在常氧(21% O2)或低氧(2% O2)条件下,突变体和对照类器官在体外均产生无法区分的 PT。完全分化的(d24)AGTR1-/-和对照类器官在免疫缺陷小鼠的肾囊下移植后能够很好地植入和成熟,而肾囊期(d14)的对照类器官也是如此。相比之下,由于血管生成素 VEGF-A 表达不足,d14 AGTR1-/-类器官无法植入。值得注意的是,在低氧条件下生长会诱导 VEGF-A 的表达,并挽救 d14 AGTR1-/-类器官的植入,而过表达 VEGF-A 也有同样的效果。我们提出,AR-RTD 中的 PT 发育不良主要是非自主性血管生成延迟的结果,在 PT 发育的关键时期使其处于饥饿状态。